한글목차

세계의 3D 세포배양 시장은 2023년에 48억 9,000만 달러로 평가되었고, 예측 기간 2023년부터 2030년까지 23.4% CAGR을 나타낼 것으로 예측되고 있습니다.

그림 1. 세계의 3D 세포배양 시장 기술별 점유율(%)(2023년)

3D 세포배양은 생물학적 세포가 3차원적으로 성장하거나 주변 환경과 상호작용할 수 있도록 인공적으로 만들어진 환경을 말합니다. 2차원 환경(페트리 접시 등)과 달리, 3D 세포배양에서 생체 외 세포는 생체 내에서와 같이 모든 방향으로 성장할 수 있습니다. 3D 세포배양은 지지 스캐폴드가 있거나 없어도 배양될 수 있습니다. 일반적으로 생물반응기라고 불리는 작은 캡슐에서 배양되며, 세포는 스페로이드(3D 세포 콜로니)로 성장합니다. 3D 스페로이드는 세포 간의 커뮤니케이션과 세포 외 기질의 발달이라는 점에서 생체 내 조직에 가깝습니다. 이러한 매트릭스는 세포가 스페로이드 내에서 살아있는 조직에서 세포의 움직임과 같은 방식으로 움직일 수 있게 합니다. 3D 세포배양은 수십년전부터 연구에 사용되었으며, 제약 화합물에 대한 세포의 반응을 평가하는 데 사용되는 시험관 내 질환 모델에도 적용되었습니다. 또한 COVID-19와의 싸움을 지원하는 다용도로 생물학적으로 관련성이 높은 연구 모델로도 점점 인기가 높아지고 있습니다.

시장 역학

주요 기업은 첨단 3D 세포배양 기술, 혁신적인 생체 재료 및 도전을 해결하고 더 나은 성능을 제공하는 문화 플랫폼을 개발하기 위해 연구 개발에 엄청난 자원을 나눕니다.

또한 특수 비계, 배양 플레이트, 바이오리액터, 마이크로플루이딕스 장치 등 3D 세포배양용 제품이 제조업체 각사로부터 끊임없이 시장에 투입되고 있으며, 이것이 시장을 더욱 견인하고 있습니다.

본 조사의 주요 특징

• 본 보고서는 세계의 3D 세포배양 시장을 상세하게 분석하여 2022년을 기준년으로 한 예측기간(2023-2030년) 시장 규모 및 연간 평균 성장률(CAGR%)을 제공합니다.
• 또한 다양한 부문에 걸친 잠재적인 성장 수익 기회를 밝히고, 이 시장에 대한 매력적인 투자 제안의 매트릭스를 설명합니다.
• 또한 시장 성장 촉진요인, 억제요인, 기회, 신제품 출시 및 승인, 시장 동향, 지역별 전망, 주요 기업이 채용하는 경쟁 전략 등에 관한 주요 인사이트도 제공합니다.
• 세계 3D 세포배양 시장의 주요 기업을 기업 하이라이트, 제품 포트폴리오, 주요 하이라이트, 성과, 전략 등의 매개변수를 기반으로 프로파일링합니다.
• 이 보고서의 인사이트를 통해 마케팅 담당자와 기업 경영진이 향후 제품 출시, 유형 업그레이드, 시장 확대, 마케팅 전술에 대한 정보를 바탕으로 의사 결정을 내릴 수 있습니다.
• 세계의 3D 세포배양 시장 보고서는 투자자, 공급업체, 제품 제조업체, 유통업체, 신규 참가자, 재무 분석가 등 이 업계의 다양한 이해 관계자를 지원합니다.
• 이해관계자들은 세계의 3D 세포배양 시장 분석에 사용되는 다양한 전략 매트릭스를 통해 의사결정이 용이해집니다.

목차

제1장 조사의 목적 및 전제조건

• 조사 목적
• 가정
• 약어

제2장 시장 전망

• 보고서 설명
  • 시장 정의 및 범위
• 주요 요약
• Coherent Opportunity Map(COM)

제3장 시장 역학, 규제 및 동향 분석

• 시장 역학
  • 성장 촉진요인
  • 억제요인
  • 시장 기회
• 영향 분석
• 시장 동향
• USFDA의 규제 시나리오
• 최근 제품 출시
• PEST 분석
• 기술의 진보
• 합병 및 인수
• 주요 하이라이트

제4장 세계의 3D 세포배양 시장-COVID-19의 영향 분석

• 경제적 영향
• COVID-19의 역학
• 수요 및 공급에 미치는 영향

제5장 세계의 3D 세포배양 시장-기술별(2018-2030년)

• 세포외 매트릭스 및 비계
• 바이오리액터
• 겔
• 비 비계 플랫폼
• 마이크로칩

제6장 세계의 3D 세포배양 시장-용도별(2018-2030년)

• 연구
• 창약
• 조직 공학
• 임상 응용
• 줄기세포 생물학

제7장 세계의 3D 세포배양 시장-최종 사용자별(2018-2030년)

• 연구실 및 기관
• 바이오의약품 산업
• 병원 및 진단센터
• 기타

제8장 세계의 3D 세포배양 시장-지역별(2018-2030년)

• 북미
• 미국
• 캐나다
• 유럽
• 영국
• 독일
• 이탈리아
• 프랑스
• 스페인
• 러시아
• 기타 유럽
• 아시아태평양
• 중국
• 인도
• 일본
• ASEAN
• 호주
• 한국
• 기타 아시아태평양
• 라틴아메리카
• 브라질
• 멕시코
• 아르헨티나
• 기타 라틴아메리카
• 중동
• GCC
• 이스라엘
• 기타 중동
• 아프리카
• 북아프리카
• 중앙 아프리카
• 남아프리카

제9장 경쟁 구도

• 기업 프로파일
  • Becton, Dickinson and Company
  • Thermo Fisher Scientific Inc
  • Lonza
  • Merck KGaA
  • 3D Biotek LLC
  • 3D Biomatrix, Inc.
  • InSphero AG
  • REPROCELL Inc.

제10장 부문

• 참고문헌
• 조사 방법

영문목차

The Global 3d Cell Culture Market is estimated to be valued at US$ 4.89 Billion in 2023 and is expected to exhibit a CAGR of 23.4% during the forecast period (2023-2030).

Figure 1. Global 3D Cell Culture Market Share (%), By Technology, 2023

A 3D cell culture is an artificially created environment in which biological cells are permitted to grow or interact with their surroundings in all three dimensions. Unlike 2D environments (e.g., a Petri dish), a 3D cell culture allows cells in vitro to grow in all directions, similar to how they would in vivo. 3D cell cultures can be grown with or without a supporting scaffold. They are usually grown in bioreactors, small capsules in which the cells can grow into spheroids, or 3D cell colonies. 3D spheroids more closely resemble in vivo tissue in terms of cellular communication and the development of extracellular matrices. These matrices help the cells to be able to move within their spheroid similar to the way cells would move in a living tissue. 3D cell cultures have been used in research for several decades and have been applied to in vitro disease models used to evaluate cellular responses to pharmaceutical compounds. They are also becoming increasingly popular as versatile and biologically relevant research models to support the fight against COVID-19.

Market Dynamics

Key companies are allocating significant resources in research and development to create advanced 3D cell culture technologies, innovative biomaterials, and culture platforms that address challenges and offer better performance. For instance, from April 8 to April 13, 2022 several emerging trends in cancer therapy were presented at the American Association for Cancer Research (AACR) 2022 Annual Meeting, and the U.K.'s Wellcome Sanger Institute summarized five key issues: early diagnosis in the pre-cancer stage; targeting the microenvironment; equity and representation from underrepresented populations; novel biomarker evaluation; and personalized therapeutics. Each issue pointed to cancer models using 3D cell culture as a solution.

Moreover, products for 3D cell culture, such as specialized scaffolds, culture plates, bioreactors, and microfluidic devices, are constantly being introduced to the market by manufacturers which is driving the market further. For instance, in December 2020, eNuvio, a company which designs and produces new cutting-edge tools for the life science research, drug discovery, and safety assessment markets, Montreal, Canada, announced the release of the first completely reusable 3D cell culture microplate on the market: the EB-Plate.

Key features of the study:

• This report provides an in-depth analysis of the global 3D cell culture market, and provides market size (US$ Bn) and Compound Annual Growth Rate (CAGR%) for the forecast period (2023-2030), considering 2022 as the base year
• It elucidates potential growth revenue opportunities across different segments and explains attractive investment proposition matrices for this market
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
• It profiles key players in the global 3D cell culture market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
• The key companies covered as a part of this study include Becton, Dickinson and Company, Thermo Fisher Scientific Inc., Lonza, Merck KGaA, 3D Biotek LLC, 3D Biomatrix, Inc., 3D Biomatrix, Inc., and REPROCELL Inc.
• Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
• The global 3D cell culture market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global 3D cell culture market

Detailed Segmentation:

• By Technology:
  • Extracellular Matrices or Scaffolds
  • Bioreactors
  • Gels
  • Scaffold-free Platforms
  • Microchips
• By Application:
  • Research
  • Drug Discovery
  • Tissue Engineering
  • Clinical Applications
  • Stem Cell Biology
• By End User:
  • Research Labs & Institutes
  • Biopharmaceutical Industry
  • Hospitals And Diagnostic Centers
  • Others
• By Region:
  • North America
  • Latin America
  • Europe
  • Asia Pacific
  • Middle East
  • Africa
• Company Profiles
  • Becton, Dickinson and Company
  • Thermo Fisher Scientific Inc.
  • Lonza
  • Merck KGaA
  • 3D Biotek LLC
  • 3D Biomatrix, Inc.
  • InSphero AG
  • REPROCELL Inc

Table of Contents

1. Research Objective and Assumption

• Research Objectives
• Assumptions
• Abbreviations

2. Market Purview

• Report Description
  • Market Definition and Scope
• Executive Summary
  • Market Snippet, By Technology
  • Market Snippet, By Application
  • Market Snippet, By End User
  • Market Snippet, By Region
• Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

• Market Dynamics
  • Drivers
  • Restraints
  • Market Opportunities
• Impact Analysis
• Market Trends
• USFDA Regulatory Scenario
• Recent Product Launches
• Pest Analysis
• Technological Advancements
• Mergers & Acquisitions
• Key Highlights

4. Global 3D Cell Culture Market - COVID-19 Impact Analysis

• Economic Impact
• COVID-19 Epidemiology
• Impact on Supply and Demand

5. Global 3D Cell Culture Market, By Technology, 2018- 2030, (US$ Bn)

• Introduction
  • Market Share Analysis, 2023 and 2030 (%)
  • Y-o-Y Growth Analysis, 2019-2030
  • Segment Trends
• Extracellular Matrices or Scaffolds
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
  • Segment Trends
• Bioreactors
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
  • Segment Trends
• Gels
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
  • Segment Trends
• Scaffold-free Platforms
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
  • Segment Trends
• Microchips
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
  • Segment Trends

6. Global 3D Cell Culture Market, By Application, 2018-2030, (US$ Bn)

• Introduction
  • Market Share Analysis, 2023 and 2030 (%)
  • Y-o-Y Growth Analysis, 2019-2030
  • Segment Trends
• Research
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
  • Segment Trends
• Drug Discovery
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
  • Segment Trends
• Tissue Engineering
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
  • Segment Trends
• Clinical Applications
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
  • Segment Trends
• Stem Cell Biology
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
  • Segment Trends

7. Global 3D Cell Culture Market, By End User, 2018-2030, (US$ Bn)

• Introduction
  • Market Share Analysis, 2023 and 2030 (%)
  • Y-o-Y Growth Analysis, 2019-2030
  • Segment Trends
• Research Labs & Institutes
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
• Biopharmaceutical Industry
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
• Hospitals And Diagnostic Centers
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
• Others
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)

8. Global 3D Cell Culture Market, By Region, 2018-2030, (US$ Bn)

• Introduction
  • Market Share Analysis, 2023 and 2030 (%)
  • Y-o-Y Growth Analysis, 2019-2030
  • Segment Trends
• North America
  • Introduction
  • Market Size and Forecast, Y-o-Y Growth and By Technology, 2018 -2030, (US$ Bn)
  • Market Size and Forecast, Y-o-Y Growth and By Application, 2018 -2030, (US$ Bn)
  • Market Size and Forecast, Y-o-Y Growth and By End User, 2018-2030, (US$ Bn)
  • Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2018 -2030, (US$ Bn)
• U.S.
• Canada
• Europe
  • Introduction
  • Market Size and Forecast, Y-o-Y Growth and By Technology, 2018 -2030, (US$ Bn)
  • Market Size and Forecast, Y-o-Y Growth and By Application, 2018 -2030, (US$ Bn)
  • Market Size and Forecast, Y-o-Y Growth and By End User, 2018-2030, (US$ Bn)
  • Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2018 -2030, (US$ Bn)
• U.K.
• Germany
• Italy
• France
• Spain
• Russia
• Rest of Europe
• Asia Pacific
  • Introduction
  • Market Size and Forecast, Y-o-Y Growth and By Technology, 2018 -2030, (US$ Bn)
  • Market Size and Forecast, Y-o-Y Growth and By Application, 2018 -2030, (US$ Bn)
  • Market Size and Forecast, Y-o-Y Growth and By End User, 2018-2030, (US$ Bn)
  • Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2018 -2030, (US$ Bn)
• China
• India
• Japan
• ASEAN
• Australia
• South Korea
• Rest of Asia Pacific
• Latin America
  • Introduction
  • Market Size and Forecast, Y-o-Y Growth and By Technology, 2018 -2030, (US$ Bn)
  • Market Size and Forecast, Y-o-Y Growth and By Application, 2018 -2030, (US$ Bn)
  • Market Size and Forecast, Y-o-Y Growth and By End User, 2018-2030, (US$ Bn)
  • Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2018 -2030, (US$ Bn)
• Brazil
• Mexico
• Argentina
• Rest of Latin America
• Middle East
  • Introduction
  • Market Size and Forecast, Y-o-Y Growth and By Technology, 2018 -2030, (US$ Bn)
  • Market Size and Forecast, Y-o-Y Growth and By Application, 2018 -2030, (US$ Bn)
  • Market Size and Forecast, Y-o-Y Growth and By End User, 2018-2030, (US$ Bn)
  • Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2018 -2030, (US$ Bn)
• GCC
• Israel
• Rest of Middle East
• Africa
  • Introduction
  • Market Size and Forecast, Y-o-Y Growth and By Technology, 2018 -2030, (US$ Bn)
  • Market Size and Forecast, Y-o-Y Growth and By Application, 2018 -2030, (US$ Bn)
  • Market Size and Forecast, Y-o-Y Growth and By End User, 2018-2030, (US$ Bn)
  • Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2018 -2030, (US$ Bn)
• North Africa
• Central Africa
• South Africa

9. Competitive Landscape

• Company Profiles
  • Becton, Dickinson and Company
• Company Overview
• Product Portfolio
• Key Highlights
• Financial Overview
• Strategies
  • Thermo Fisher Scientific Inc
  • Lonza
  • Merck KGaA
  • 3D Biotek LLC
  • 3D Biomatrix, Inc.
  • InSphero AG
  • REPROCELL Inc.

10. Section

• References
• Research Methodology
• About us and Sales Contact